Skip to content

Evaluation of different body positions on the safety of painless endoscopy

Evaluation of different body positions on the safety of painless endoscopy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051946
Enrollment
Unknown
Registered
2021-10-09
Start date
2021-10-09
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract diseases

Interventions

Case series:None

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.ASA classification 1-2; 2.Plan gastroscopy and polypectomy under gastroscopy; 3.Aged 18 to 65 years; 4.BMI18-23.9; 5.Patients and their families gave informed consent to the study; 6.Patients can cooperate.

Exclusion criteria

Exclusion criteria: 1.Long-term alcoholism and tolerance to narcotic drugs; 2.Patients who are allergic to the drugs used in this study; 3.Patients with delayed gastric emptying; 4.Achalasia syndrome of cardia; 5.Gastroesophageal reflux syndrome; 6.Patients who fasted for less than 8 hours; 7.Patients using drugs that cause esophageal sphincter relaxation; 8.Patients with long-term pain and anxiety; 9.Patients with oxygen saturation less than or equal to 95% before examination; 10.Difficult airway and severe respiratory disease (obstructive sleep apnea syndrome, mouth opening disorder, restricted neck or jaw movement, morbid obesity, acute respiratory infection, acute exacerbation of chronic obstructive pulmonary disease, uncontrolled asthma, etc.); 11.Preoperative visit blood pressure >=180/110 mm Hg (WHO-ISH hypertension guideline grade 3 hypertension); 12.Patients with a history of gastrointestinal surgery; 13.Patients enrolled in other studies within 30 days; 14.The shallow anesthesia causes the patient to have a severe coughing reaction; 15.Anemia patients.

Design outcomes

Primary

MeasureTime frame
Pepsin;

Secondary

MeasureTime frame
Ventilation;

Countries

China

Contacts

Public ContactJiang Ke

Affiliated Hospital of Guizhou Medical University

1593260045@qq.com+86 13232742117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026